Reata Pharmaceuticals
Why Robinhood?
You can watch RETA and buy or sell other stocks, ETFs, and their options commission-free!About RETA
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
RETA Key Statistics
Stock Snapshot
The current Reata Pharmaceuticals(RETA) stock price is $172.36, with a market capitalization of 6.57B. The stock trades at a price-to-earnings (P/E) ratio of -57.67.
On 2026-02-11, Reata Pharmaceuticals(RETA) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 610.38K.
The stock's 52-week range extends from a low of $21.83 to a high of $172.46.
The stock's 52-week range extends from a low of $21.83 to a high of $172.46.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.